Who is affected and how:

• People with epilepsy and their families: May benefit from better-coordinated federal strategies, clearer national priorities, improved data collection, and evidence-based recommendations that aim to reduce uncontrolled seizures, reduce early mortality, and improve access to care and supports.

• Health care providers and clinical systems: May receive federal guidance, recommended care coordination practices, and measurement tools; some providers could be asked to contribute data for national surveillance and assessments.

• Researchers and public‑health agencies: Will be asked to share data and align on metrics, which can improve surveillance, identify disparities, and spur targeted research and program development.

• HHS and other federal agencies: Will take on new planning, reporting, and coordination responsibilities, and must allocate staff time and potentially resources to support advisory council operation, interagency data exchange, and annual reporting.

• State and local public-health entities and partners: Could be engaged to supply data, implement recommended practices, and cooperate on measurement and interventions—though the law does not appear to impose direct financial mandates on states.

Net effects: The measure centralizes federal attention on epilepsy, improves cross-agency coordination, and sets public-reporting and advisory processes intended to guide policy and program decisions. Implementation will require administrative work by federal agencies and cooperation from researchers and health systems; because no specific appropriation is included in the text provided, agencies will likely need to use existing budgets or seek future funding to fully execute all duties.